<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:arxiv="http://arxiv.org/schemas/atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>q-bio.GN updates on arXiv.org</title>
    <link>http://rss.arxiv.org/rss/q-bio.GN</link>
    <description>q-bio.GN updates on the arXiv.org e-print archive.</description>
    <atom:link href="http://rss.arxiv.org/rss/q-bio.GN" rel="self" type="application/rss+xml"/>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <language>en-us</language>
    <lastBuildDate>Fri, 21 Nov 2025 05:00:01 +0000</lastBuildDate>
    <managingEditor>rss-help@arxiv.org</managingEditor>
    <pubDate>Fri, 21 Nov 2025 00:00:00 -0500</pubDate>
    <skipDays>
      <day>Saturday</day>
      <day>Sunday</day>
    </skipDays>
    <item>
      <title>Efficient Chromosome Parallelization for Precision Medicine Genomic Workflows</title>
      <link>https://arxiv.org/abs/2511.15977</link>
      <description>arXiv:2511.15977v1 Announce Type: cross 
Abstract: Large-scale genomic workflows used in precision medicine can process datasets spanning tens to hundreds of gigabytes per sample, leading to high memory spikes, intensive disk I/O, and task failures due to out-of-memory errors. Simple static resource allocation methods struggle to handle the variability in per-chromosome RAM demands, resulting in poor resource utilization and long runtimes. In this work, we propose multiple mechanisms for adaptive, RAM-efficient parallelization of chromosome-level bioinformatics workflows. First, we develop a symbolic regression model that estimates per-chromosome memory consumption for a given task and introduces an interpolating bias to conservatively minimize over-allocation. Second, we present a dynamic scheduler that adaptively predicts RAM usage with a polynomial regression model, treating task packing as a Knapsack problem to optimally batch jobs based on predicted memory requirements. Additionally, we present a static scheduler that optimizes chromosome processing order to minimize peak memory while preserving throughput. Our proposed methods, evaluated on simulations and real-world genomic pipelines, provide new mechanisms to reduce memory overruns and balance load across threads. We thereby achieve faster end-to-end execution, showcasing the potential to optimize large-scale genomic workflows.</description>
      <guid isPermaLink="false">oai:arXiv.org:2511.15977v1</guid>
      <category>cs.DC</category>
      <category>cs.AI</category>
      <category>cs.LG</category>
      <category>cs.PF</category>
      <category>q-bio.GN</category>
      <pubDate>Fri, 21 Nov 2025 00:00:00 -0500</pubDate>
      <arxiv:announce_type>cross</arxiv:announce_type>
      <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
      <dc:creator>Daniel Mas Montserrat, Ray Verma, M\'iriam Barrab\'es, Francisco M. de la Vega, Carlos D. Bustamante, Alexander G. Ioannidis</dc:creator>
    </item>
    <item>
      <title>Effect Size-Driven Pathway Meta-Analysis for Gene Expression Data</title>
      <link>https://arxiv.org/abs/2501.13583</link>
      <description>arXiv:2501.13583v2 Announce Type: replace-cross 
Abstract: The proliferation of omics datasets in public repositories has created unprecedented opportunities for biomedical research but has also posed significant challenges for their integration, particularly due to missing genes and platform-specific discrepancies. Traditional gene expression metaanalysis often focuses on individual genes, leading to data loss and limited biological insights when there are missing genes across different studies. To address these limitations, we propose GSEMA (Gene Set Enrichment Meta-Analysis), a novel methodology that leverages singlesample enrichment scoring to aggregate gene expression data into pathway-level matrices. By applying meta-analysis techniques to enrichment scores, GSEMA preserves the magnitude and directionality of effects, enabling the definition of pathway activity across datasets. Using simulated data and case studies on Systemic Lupus Erythematosus (SLE) and Parkinson's Disease (PD), we demonstrate that GSEMA outperforms other methods in controlling false positive rates while providing meaningful biological interpretations. GSEMA methodology is implemented as an R package available on CRAN repository</description>
      <guid isPermaLink="false">oai:arXiv.org:2501.13583v2</guid>
      <category>stat.AP</category>
      <category>q-bio.GN</category>
      <pubDate>Fri, 21 Nov 2025 00:00:00 -0500</pubDate>
      <arxiv:announce_type>replace-cross</arxiv:announce_type>
      <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
      <dc:creator>Juan Antonio Villatoro-Garc\'ia, Pablo Pedro Jurado-Basc\'on, Pedro Carmona-S\'aez</dc:creator>
    </item>
  </channel>
</rss>
